http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 04 Jun 2026 11:12:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Press+Releases/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html <ul><li>15 World firsts claimed by the Company in patent applications filed<br/></li><li>Discoveries enhance MindBio’s commercialization pipeline for the detection of neurologically active substances non-invasively, using Voice and AI.</li><li style="margin-bottom:12pt;">MindBio is on track for delivery of its initial commercial prototype this quarter.<br/><br/></li></ul> <p align="justify">VANCOUVER, British Columbia, June 04, 2026 (GLOBE NEWSWIRE) -- <strong>MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF), </strong>(the “<strong>Company</strong>” or “<strong>MindBio</strong>”), a biotechnology company commercializing AI-driven voice analytics for drug and alcohol intoxication detection, is pleased to announce the Company has launched its lead commercial software Intox AI™ for validation and testing.</p> <p align="justify">MindBio’s enterprise solution http://www.streetinsider.com/Globe+Newswire/MindBio+Launches+Intox+AI%E2%84%A2%C2%A0in+Major+Advancement+for+Drug+Use+Detection/26604121.html Thu, 04 Jun 2026 11:12:00 -0400 MBIO MBQIF O.60784024 WF6.F WF60 http://www.streetinsider.com/Press+Releases/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html <p>AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SmCvKcO2PnGrNIbnPSsjaeVltiaRWAv2BECM440g4U1soByF2PlhyFI1dqrGYq9FFt6YKSb31NlwkIWXL9Nkv9_UQ2ruN1MTQrnxlzOLf5w=" rel="nofollow" target="_blank">IBN</a> – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JR81LjpHIUaqDSJnjVZMs4hn7FqQKrpYMGsFGf7tIz9RuO9bGF840NMT1AWX7QT3D1IPYvebBFbfKqj75STMT13v7KsoOnKs-kvWls2O6wagzRXIqfSzJ_HKnijZmVaqOwbU4wgrWtsvkyscXETBhk8JUyFgpbNWTh7Lib-LB2k=" rel="nofollow" target="_blank">MindBio Therapeutics Corp. </a>(CSE: MBIO) (OTCQB: MBQIF).</p> <p>To hear the NetworkNewsAudio version, visit <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD1KDNKtW8SQYnuX2gbkPElb1Wq6wGI9R4-zxenVtuU8q12bf08X8gOneje9MVsLU7QM5ItoeZE_KuQk_9cUewGw=" rel="nofollow" target="_blank">https://nnw.fm/aG7X2</a> </p> <p>To read the original editorial, visit: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD7z29m4ppJ546wgo4VhBhhSCGSrnPCMYvY6VgxO5Vj-D-ypJCnl6lYANr2jSynB_UWoxRDDox1wCWDbmHx56VKM=" rel="nofollow" target="_blank">https://nnw.fm/9720C</a></p> <p style="padding-left:40px;">MindBio Therapeutics is establishing a unique position in the emerging field of voice-based diagnostics by combining artificial intelligence with speech analysis to detect intoxication. Unlike traditional testing methods, which require physical samples http://www.streetinsider.com/Press+Releases/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html Fri, 15 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Press+Releases/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html <p>AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SmCvKcO2PnGrNIbnPSsjaeVltiaRWAv2BECM440g4U1soByF2PlhyFI1dqrGYq9FFt6YKSb31NlwkIWXL9Nkv9_UQ2ruN1MTQrnxlzOLf5w=" rel="nofollow" target="_blank">IBN</a> – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JR81LjpHIUaqDSJnjVZMs4hn7FqQKrpYMGsFGf7tIz9RuO9bGF840NMT1AWX7QT3D1IPYvebBFbfKqj75STMT13v7KsoOnKs-kvWls2O6wagzRXIqfSzJ_HKnijZmVaqOwbU4wgrWtsvkyscXETBhk8JUyFgpbNWTh7Lib-LB2k=" rel="nofollow" target="_blank">MindBio Therapeutics Corp. </a>(CSE: MBIO) (OTCQB: MBQIF).</p> <p>To hear the NetworkNewsAudio version, visit <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD1KDNKtW8SQYnuX2gbkPElb1Wq6wGI9R4-zxenVtuU8q12bf08X8gOneje9MVsLU7QM5ItoeZE_KuQk_9cUewGw=" rel="nofollow" target="_blank">https://nnw.fm/aG7X2</a> </p> <p>To read the original editorial, visit: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD7z29m4ppJ546wgo4VhBhhSCGSrnPCMYvY6VgxO5Vj-D-ypJCnl6lYANr2jSynB_UWoxRDDox1wCWDbmHx56VKM=" rel="nofollow" target="_blank">https://nnw.fm/9720C</a></p> <p style="padding-left:40px;">MindBio Therapeutics is establishing a unique position in the emerging field of voice-based diagnostics by combining artificial intelligence with speech analysis to detect intoxication. Unlike traditional testing methods, which require physical samples http://www.streetinsider.com/Press+Releases/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html Fri, 15 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Press+Releases/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html <p>AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SmCvKcO2PnGrNIbnPSsjaeVltiaRWAv2BECM440g4U1soByF2PlhyFI1dqrGYq9FFt6YKSb31NlwkIWXL9Nkv9_UQ2ruN1MTQrnxlzOLf5w=" rel="nofollow" target="_blank">IBN</a> – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JR81LjpHIUaqDSJnjVZMs4hn7FqQKrpYMGsFGf7tIz9RuO9bGF840NMT1AWX7QT3D1IPYvebBFbfKqj75STMT13v7KsoOnKs-kvWls2O6wagzRXIqfSzJ_HKnijZmVaqOwbU4wgrWtsvkyscXETBhk8JUyFgpbNWTh7Lib-LB2k=" rel="nofollow" target="_blank">MindBio Therapeutics Corp. </a>(CSE: MBIO) (OTCQB: MBQIF).</p> <p>To hear the NetworkNewsAudio version, visit <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD1KDNKtW8SQYnuX2gbkPElb1Wq6wGI9R4-zxenVtuU8q12bf08X8gOneje9MVsLU7QM5ItoeZE_KuQk_9cUewGw=" rel="nofollow" target="_blank">https://nnw.fm/aG7X2</a> </p> <p>To read the original editorial, visit: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD7z29m4ppJ546wgo4VhBhhSCGSrnPCMYvY6VgxO5Vj-D-ypJCnl6lYANr2jSynB_UWoxRDDox1wCWDbmHx56VKM=" rel="nofollow" target="_blank">https://nnw.fm/9720C</a></p> <p style="padding-left:40px;">MindBio Therapeutics is establishing a unique position in the emerging field of voice-based diagnostics by combining artificial intelligence with speech analysis to detect intoxication. Unlike traditional testing methods, which require physical samples http://www.streetinsider.com/Press+Releases/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html Fri, 15 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Globe+Newswire/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html <p>AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SmCvKcO2PnGrNIbnPSsjaeVltiaRWAv2BECM440g4U1soByF2PlhyFI1dqrGYq9FFt6YKSb31NlwkIWXL9Nkv9_UQ2ruN1MTQrnxlzOLf5w=" rel="nofollow" target="_blank">IBN</a> – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JR81LjpHIUaqDSJnjVZMs4hn7FqQKrpYMGsFGf7tIz9RuO9bGF840NMT1AWX7QT3D1IPYvebBFbfKqj75STMT13v7KsoOnKs-kvWls2O6wagzRXIqfSzJ_HKnijZmVaqOwbU4wgrWtsvkyscXETBhk8JUyFgpbNWTh7Lib-LB2k=" rel="nofollow" target="_blank">MindBio Therapeutics Corp. </a>(CSE: MBIO) (OTCQB: MBQIF).</p> <p>To hear the NetworkNewsAudio version, visit <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD1KDNKtW8SQYnuX2gbkPElb1Wq6wGI9R4-zxenVtuU8q12bf08X8gOneje9MVsLU7QM5ItoeZE_KuQk_9cUewGw=" rel="nofollow" target="_blank">https://nnw.fm/aG7X2</a> </p> <p>To read the original editorial, visit: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD7z29m4ppJ546wgo4VhBhhSCGSrnPCMYvY6VgxO5Vj-D-ypJCnl6lYANr2jSynB_UWoxRDDox1wCWDbmHx56VKM=" rel="nofollow" target="_blank">https://nnw.fm/9720C</a></p> <p style="padding-left:40px;">MindBio Therapeutics is establishing a unique position in the emerging field of voice-based diagnostics by combining artificial intelligence with speech analysis to detect intoxication. Unlike traditional testing methods, which require physical samples http://www.streetinsider.com/Globe+Newswire/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html Fri, 15 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Globe+Newswire/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html <p>AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SmCvKcO2PnGrNIbnPSsjaeVltiaRWAv2BECM440g4U1soByF2PlhyFI1dqrGYq9FFt6YKSb31NlwkIWXL9Nkv9_UQ2ruN1MTQrnxlzOLf5w=" rel="nofollow" target="_blank">IBN</a> – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JR81LjpHIUaqDSJnjVZMs4hn7FqQKrpYMGsFGf7tIz9RuO9bGF840NMT1AWX7QT3D1IPYvebBFbfKqj75STMT13v7KsoOnKs-kvWls2O6wagzRXIqfSzJ_HKnijZmVaqOwbU4wgrWtsvkyscXETBhk8JUyFgpbNWTh7Lib-LB2k=" rel="nofollow" target="_blank">MindBio Therapeutics Corp. </a>(CSE: MBIO) (OTCQB: MBQIF).</p> <p>To hear the NetworkNewsAudio version, visit <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD1KDNKtW8SQYnuX2gbkPElb1Wq6wGI9R4-zxenVtuU8q12bf08X8gOneje9MVsLU7QM5ItoeZE_KuQk_9cUewGw=" rel="nofollow" target="_blank">https://nnw.fm/aG7X2</a> </p> <p>To read the original editorial, visit: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD7z29m4ppJ546wgo4VhBhhSCGSrnPCMYvY6VgxO5Vj-D-ypJCnl6lYANr2jSynB_UWoxRDDox1wCWDbmHx56VKM=" rel="nofollow" target="_blank">https://nnw.fm/9720C</a></p> <p style="padding-left:40px;">MindBio Therapeutics is establishing a unique position in the emerging field of voice-based diagnostics by combining artificial intelligence with speech analysis to detect intoxication. Unlike traditional testing methods, which require physical samples http://www.streetinsider.com/Globe+Newswire/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html Fri, 15 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Globe+Newswire/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html <p>AUSTIN, Texas, May 15, 2026 (GLOBE NEWSWIRE) -- via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SmCvKcO2PnGrNIbnPSsjaeVltiaRWAv2BECM440g4U1soByF2PlhyFI1dqrGYq9FFt6YKSb31NlwkIWXL9Nkv9_UQ2ruN1MTQrnxlzOLf5w=" rel="nofollow" target="_blank">IBN</a> – NetworkNewsAudio announces the Audio Press Release (APR) titled “The Future of Intoxication Detection May Be in Your Voice,” featuring <a target="_blank" href="https://www.globenewswire.com/Tracker?data=JR81LjpHIUaqDSJnjVZMs4hn7FqQKrpYMGsFGf7tIz9RuO9bGF840NMT1AWX7QT3D1IPYvebBFbfKqj75STMT13v7KsoOnKs-kvWls2O6wagzRXIqfSzJ_HKnijZmVaqOwbU4wgrWtsvkyscXETBhk8JUyFgpbNWTh7Lib-LB2k=" rel="nofollow" target="_blank">MindBio Therapeutics Corp. </a>(CSE: MBIO) (OTCQB: MBQIF).</p> <p>To hear the NetworkNewsAudio version, visit <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD1KDNKtW8SQYnuX2gbkPElb1Wq6wGI9R4-zxenVtuU8q12bf08X8gOneje9MVsLU7QM5ItoeZE_KuQk_9cUewGw=" rel="nofollow" target="_blank">https://nnw.fm/aG7X2</a> </p> <p>To read the original editorial, visit: <a target="_blank" href="https://www.globenewswire.com/Tracker?data=VeKTtKH7EKF1S4vGApNiD7z29m4ppJ546wgo4VhBhhSCGSrnPCMYvY6VgxO5Vj-D-ypJCnl6lYANr2jSynB_UWoxRDDox1wCWDbmHx56VKM=" rel="nofollow" target="_blank">https://nnw.fm/9720C</a></p> <p style="padding-left:40px;">MindBio Therapeutics is establishing a unique position in the emerging field of voice-based diagnostics by combining artificial intelligence with speech analysis to detect intoxication. Unlike traditional testing methods, which require physical samples http://www.streetinsider.com/Globe+Newswire/NetworkNews+Audio+Announces+Audio+Press+Release+%28APR%29+Discussing+Combining+Artificial+Intelligence+with+Speech+Analysis+to+Detect+Intoxication/26500068.html Fri, 15 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Press+Releases/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html <p><i>Disseminated on behalf of</i> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocWNxOhMsUdaDoI-EAvymwG3txg9Rj1fo29DSHr-YAlPtKL29W3fCc4bRDK8zzzQiLlSBi2AfEqHcqvFvlvq1s5jwjXhAL-GMRaVynO6E3y75WJdeCT4F3t7mqPkMyicnt2DBsBbh2dDfHOY4JJsVtenE1SlnSJF6oMqheek-nRB8A==" rel="nofollow" target="_blank"><i>MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)</i></a> <i>and may include paid advertising.</i></p> <p><i>NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- </i>via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPlh7HMU62uP_P3IKjqI7PRhTu5Eoxoi6y9K3FCIFhobDPW3IXI_S4rmwPk1ohhY-TRg==" rel="nofollow" target="_blank">BioMedWire</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocUEIjmvBEPZB9Gk5kxTcYdge2FHWRbEMXLsmBWoDM3M8Wdgov3g_HHBxNuw3QzHwHFYLMbaj2zzU1eFPgAUl5vE5d5LXtBKJ8QB8hFcKDxeiYvpKMu8Grvo67tj9_ZqP6Er4WbMaKFSi0T2m1vZ6xBk" rel="nofollow" target="_blank">MindBio Therapeutics Corp.</a> (CSE: MBIO) (OTCQB: MBQIF) today announces its placement in an editorial published by <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPltX4qaF5h8O4EUzzIzPCfSJSzQLb-2ppzSZtTNLAmG8TlNVOAGCrPxGbXjBCOqQ-kw==" rel="nofollow" target="_blank">BioMedWire</a> (BMW), one of 75+ brands within the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=mYqQNG9z7NB7WZ32A1B1u8DqF7SmGaCTHBDcG5wdDDgUt-wY2U4EYGTlHYQxhfBiXXAIA20_TfoMLn6iV18Ag_o3uwpA-NlYFjpdNMC0xHdpJpkXTI2QqFHlaqxzMSSENV3pFc_9qRy1CawI4tgZ7Q==" rel="nofollow" target="_blank">Dynamic Brand Portfolio</a>@<a target="_blank" href="https://www.globenewswire.com/Tracker?data=P085T8U10ySizO2LEj9j-noNDS-t28BCcN2jBI6P7S_2oTw5Aee8R5C49WFyaDid1CTMTD4FMsE_1j3t7XyE3AUDYZpkMyP0lsxKEJs5gFI=" rel="nofollow" target="_blank">IBN</a> (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=eji2SInXzxzPDQjO9lBFqhy0I58Dved-K29bI-ktWj7HoKgFBuTiOhZeij5t44GuFCBc5dujzLDKaiF77Y3myLbUVAxfR32sgKWTdiD1MtiOGpjU1VHZL_HVMetFpGUz" rel="nofollow" target="_blank">InvestorBrandNetwork</a>), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the http://www.streetinsider.com/Press+Releases/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html Thu, 14 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Press+Releases/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html <p><i>Disseminated on behalf of</i> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocWNxOhMsUdaDoI-EAvymwG3txg9Rj1fo29DSHr-YAlPtKL29W3fCc4bRDK8zzzQiLlSBi2AfEqHcqvFvlvq1s5jwjXhAL-GMRaVynO6E3y75WJdeCT4F3t7mqPkMyicnt2DBsBbh2dDfHOY4JJsVtenE1SlnSJF6oMqheek-nRB8A==" rel="nofollow" target="_blank"><i>MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)</i></a> <i>and may include paid advertising.</i></p> <p><i>NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- </i>via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPlh7HMU62uP_P3IKjqI7PRhTu5Eoxoi6y9K3FCIFhobDPW3IXI_S4rmwPk1ohhY-TRg==" rel="nofollow" target="_blank">BioMedWire</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocUEIjmvBEPZB9Gk5kxTcYdge2FHWRbEMXLsmBWoDM3M8Wdgov3g_HHBxNuw3QzHwHFYLMbaj2zzU1eFPgAUl5vE5d5LXtBKJ8QB8hFcKDxeiYvpKMu8Grvo67tj9_ZqP6Er4WbMaKFSi0T2m1vZ6xBk" rel="nofollow" target="_blank">MindBio Therapeutics Corp.</a> (CSE: MBIO) (OTCQB: MBQIF) today announces its placement in an editorial published by <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPltX4qaF5h8O4EUzzIzPCfSJSzQLb-2ppzSZtTNLAmG8TlNVOAGCrPxGbXjBCOqQ-kw==" rel="nofollow" target="_blank">BioMedWire</a> (BMW), one of 75+ brands within the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=mYqQNG9z7NB7WZ32A1B1u8DqF7SmGaCTHBDcG5wdDDgUt-wY2U4EYGTlHYQxhfBiXXAIA20_TfoMLn6iV18Ag_o3uwpA-NlYFjpdNMC0xHdpJpkXTI2QqFHlaqxzMSSENV3pFc_9qRy1CawI4tgZ7Q==" rel="nofollow" target="_blank">Dynamic Brand Portfolio</a>@<a target="_blank" href="https://www.globenewswire.com/Tracker?data=P085T8U10ySizO2LEj9j-noNDS-t28BCcN2jBI6P7S_2oTw5Aee8R5C49WFyaDid1CTMTD4FMsE_1j3t7XyE3AUDYZpkMyP0lsxKEJs5gFI=" rel="nofollow" target="_blank">IBN</a> (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=eji2SInXzxzPDQjO9lBFqhy0I58Dved-K29bI-ktWj7HoKgFBuTiOhZeij5t44GuFCBc5dujzLDKaiF77Y3myLbUVAxfR32sgKWTdiD1MtiOGpjU1VHZL_HVMetFpGUz" rel="nofollow" target="_blank">InvestorBrandNetwork</a>), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the http://www.streetinsider.com/Press+Releases/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html Thu, 14 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Press+Releases/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html <p><i>Disseminated on behalf of</i> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocWNxOhMsUdaDoI-EAvymwG3txg9Rj1fo29DSHr-YAlPtKL29W3fCc4bRDK8zzzQiLlSBi2AfEqHcqvFvlvq1s5jwjXhAL-GMRaVynO6E3y75WJdeCT4F3t7mqPkMyicnt2DBsBbh2dDfHOY4JJsVtenE1SlnSJF6oMqheek-nRB8A==" rel="nofollow" target="_blank"><i>MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)</i></a> <i>and may include paid advertising.</i></p> <p><i>NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- </i>via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPlh7HMU62uP_P3IKjqI7PRhTu5Eoxoi6y9K3FCIFhobDPW3IXI_S4rmwPk1ohhY-TRg==" rel="nofollow" target="_blank">BioMedWire</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocUEIjmvBEPZB9Gk5kxTcYdge2FHWRbEMXLsmBWoDM3M8Wdgov3g_HHBxNuw3QzHwHFYLMbaj2zzU1eFPgAUl5vE5d5LXtBKJ8QB8hFcKDxeiYvpKMu8Grvo67tj9_ZqP6Er4WbMaKFSi0T2m1vZ6xBk" rel="nofollow" target="_blank">MindBio Therapeutics Corp.</a> (CSE: MBIO) (OTCQB: MBQIF) today announces its placement in an editorial published by <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPltX4qaF5h8O4EUzzIzPCfSJSzQLb-2ppzSZtTNLAmG8TlNVOAGCrPxGbXjBCOqQ-kw==" rel="nofollow" target="_blank">BioMedWire</a> (BMW), one of 75+ brands within the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=mYqQNG9z7NB7WZ32A1B1u8DqF7SmGaCTHBDcG5wdDDgUt-wY2U4EYGTlHYQxhfBiXXAIA20_TfoMLn6iV18Ag_o3uwpA-NlYFjpdNMC0xHdpJpkXTI2QqFHlaqxzMSSENV3pFc_9qRy1CawI4tgZ7Q==" rel="nofollow" target="_blank">Dynamic Brand Portfolio</a>@<a target="_blank" href="https://www.globenewswire.com/Tracker?data=P085T8U10ySizO2LEj9j-noNDS-t28BCcN2jBI6P7S_2oTw5Aee8R5C49WFyaDid1CTMTD4FMsE_1j3t7XyE3AUDYZpkMyP0lsxKEJs5gFI=" rel="nofollow" target="_blank">IBN</a> (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=eji2SInXzxzPDQjO9lBFqhy0I58Dved-K29bI-ktWj7HoKgFBuTiOhZeij5t44GuFCBc5dujzLDKaiF77Y3myLbUVAxfR32sgKWTdiD1MtiOGpjU1VHZL_HVMetFpGUz" rel="nofollow" target="_blank">InvestorBrandNetwork</a>), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the http://www.streetinsider.com/Press+Releases/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html Thu, 14 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Globe+Newswire/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html <p><i>Disseminated on behalf of</i> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocWNxOhMsUdaDoI-EAvymwG3txg9Rj1fo29DSHr-YAlPtKL29W3fCc4bRDK8zzzQiLlSBi2AfEqHcqvFvlvq1s5jwjXhAL-GMRaVynO6E3y75WJdeCT4F3t7mqPkMyicnt2DBsBbh2dDfHOY4JJsVtenE1SlnSJF6oMqheek-nRB8A==" rel="nofollow" target="_blank"><i>MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)</i></a> <i>and may include paid advertising.</i></p> <p><i>NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- </i>via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPlh7HMU62uP_P3IKjqI7PRhTu5Eoxoi6y9K3FCIFhobDPW3IXI_S4rmwPk1ohhY-TRg==" rel="nofollow" target="_blank">BioMedWire</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocUEIjmvBEPZB9Gk5kxTcYdge2FHWRbEMXLsmBWoDM3M8Wdgov3g_HHBxNuw3QzHwHFYLMbaj2zzU1eFPgAUl5vE5d5LXtBKJ8QB8hFcKDxeiYvpKMu8Grvo67tj9_ZqP6Er4WbMaKFSi0T2m1vZ6xBk" rel="nofollow" target="_blank">MindBio Therapeutics Corp.</a> (CSE: MBIO) (OTCQB: MBQIF) today announces its placement in an editorial published by <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPltX4qaF5h8O4EUzzIzPCfSJSzQLb-2ppzSZtTNLAmG8TlNVOAGCrPxGbXjBCOqQ-kw==" rel="nofollow" target="_blank">BioMedWire</a> (BMW), one of 75+ brands within the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=mYqQNG9z7NB7WZ32A1B1u8DqF7SmGaCTHBDcG5wdDDgUt-wY2U4EYGTlHYQxhfBiXXAIA20_TfoMLn6iV18Ag_o3uwpA-NlYFjpdNMC0xHdpJpkXTI2QqFHlaqxzMSSENV3pFc_9qRy1CawI4tgZ7Q==" rel="nofollow" target="_blank">Dynamic Brand Portfolio</a>@<a target="_blank" href="https://www.globenewswire.com/Tracker?data=P085T8U10ySizO2LEj9j-noNDS-t28BCcN2jBI6P7S_2oTw5Aee8R5C49WFyaDid1CTMTD4FMsE_1j3t7XyE3AUDYZpkMyP0lsxKEJs5gFI=" rel="nofollow" target="_blank">IBN</a> (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=eji2SInXzxzPDQjO9lBFqhy0I58Dved-K29bI-ktWj7HoKgFBuTiOhZeij5t44GuFCBc5dujzLDKaiF77Y3myLbUVAxfR32sgKWTdiD1MtiOGpjU1VHZL_HVMetFpGUz" rel="nofollow" target="_blank">InvestorBrandNetwork</a>), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the http://www.streetinsider.com/Globe+Newswire/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html Thu, 14 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Globe+Newswire/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html <p><i>Disseminated on behalf of</i> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocWNxOhMsUdaDoI-EAvymwG3txg9Rj1fo29DSHr-YAlPtKL29W3fCc4bRDK8zzzQiLlSBi2AfEqHcqvFvlvq1s5jwjXhAL-GMRaVynO6E3y75WJdeCT4F3t7mqPkMyicnt2DBsBbh2dDfHOY4JJsVtenE1SlnSJF6oMqheek-nRB8A==" rel="nofollow" target="_blank"><i>MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)</i></a> <i>and may include paid advertising.</i></p> <p><i>NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- </i>via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPlh7HMU62uP_P3IKjqI7PRhTu5Eoxoi6y9K3FCIFhobDPW3IXI_S4rmwPk1ohhY-TRg==" rel="nofollow" target="_blank">BioMedWire</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocUEIjmvBEPZB9Gk5kxTcYdge2FHWRbEMXLsmBWoDM3M8Wdgov3g_HHBxNuw3QzHwHFYLMbaj2zzU1eFPgAUl5vE5d5LXtBKJ8QB8hFcKDxeiYvpKMu8Grvo67tj9_ZqP6Er4WbMaKFSi0T2m1vZ6xBk" rel="nofollow" target="_blank">MindBio Therapeutics Corp.</a> (CSE: MBIO) (OTCQB: MBQIF) today announces its placement in an editorial published by <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPltX4qaF5h8O4EUzzIzPCfSJSzQLb-2ppzSZtTNLAmG8TlNVOAGCrPxGbXjBCOqQ-kw==" rel="nofollow" target="_blank">BioMedWire</a> (BMW), one of 75+ brands within the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=mYqQNG9z7NB7WZ32A1B1u8DqF7SmGaCTHBDcG5wdDDgUt-wY2U4EYGTlHYQxhfBiXXAIA20_TfoMLn6iV18Ag_o3uwpA-NlYFjpdNMC0xHdpJpkXTI2QqFHlaqxzMSSENV3pFc_9qRy1CawI4tgZ7Q==" rel="nofollow" target="_blank">Dynamic Brand Portfolio</a>@<a target="_blank" href="https://www.globenewswire.com/Tracker?data=P085T8U10ySizO2LEj9j-noNDS-t28BCcN2jBI6P7S_2oTw5Aee8R5C49WFyaDid1CTMTD4FMsE_1j3t7XyE3AUDYZpkMyP0lsxKEJs5gFI=" rel="nofollow" target="_blank">IBN</a> (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=eji2SInXzxzPDQjO9lBFqhy0I58Dved-K29bI-ktWj7HoKgFBuTiOhZeij5t44GuFCBc5dujzLDKaiF77Y3myLbUVAxfR32sgKWTdiD1MtiOGpjU1VHZL_HVMetFpGUz" rel="nofollow" target="_blank">InvestorBrandNetwork</a>), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the http://www.streetinsider.com/Globe+Newswire/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html Thu, 14 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Globe+Newswire/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html <p><i>Disseminated on behalf of</i> <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocWNxOhMsUdaDoI-EAvymwG3txg9Rj1fo29DSHr-YAlPtKL29W3fCc4bRDK8zzzQiLlSBi2AfEqHcqvFvlvq1s5jwjXhAL-GMRaVynO6E3y75WJdeCT4F3t7mqPkMyicnt2DBsBbh2dDfHOY4JJsVtenE1SlnSJF6oMqheek-nRB8A==" rel="nofollow" target="_blank"><i>MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)</i></a> <i>and may include paid advertising.</i></p> <p><i>NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- </i>via <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPlh7HMU62uP_P3IKjqI7PRhTu5Eoxoi6y9K3FCIFhobDPW3IXI_S4rmwPk1ohhY-TRg==" rel="nofollow" target="_blank">BioMedWire</a> -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=0FaIhLRVD87qMsBsgWZRb9zRNdDI4ZJA8YSEoydRocUEIjmvBEPZB9Gk5kxTcYdge2FHWRbEMXLsmBWoDM3M8Wdgov3g_HHBxNuw3QzHwHFYLMbaj2zzU1eFPgAUl5vE5d5LXtBKJ8QB8hFcKDxeiYvpKMu8Grvo67tj9_ZqP6Er4WbMaKFSi0T2m1vZ6xBk" rel="nofollow" target="_blank">MindBio Therapeutics Corp.</a> (CSE: MBIO) (OTCQB: MBQIF) today announces its placement in an editorial published by <a target="_blank" href="https://www.globenewswire.com/Tracker?data=SzfUu03x3nDIoyF2EzpPltX4qaF5h8O4EUzzIzPCfSJSzQLb-2ppzSZtTNLAmG8TlNVOAGCrPxGbXjBCOqQ-kw==" rel="nofollow" target="_blank">BioMedWire</a> (BMW), one of 75+ brands within the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=mYqQNG9z7NB7WZ32A1B1u8DqF7SmGaCTHBDcG5wdDDgUt-wY2U4EYGTlHYQxhfBiXXAIA20_TfoMLn6iV18Ag_o3uwpA-NlYFjpdNMC0xHdpJpkXTI2QqFHlaqxzMSSENV3pFc_9qRy1CawI4tgZ7Q==" rel="nofollow" target="_blank">Dynamic Brand Portfolio</a>@<a target="_blank" href="https://www.globenewswire.com/Tracker?data=P085T8U10ySizO2LEj9j-noNDS-t28BCcN2jBI6P7S_2oTw5Aee8R5C49WFyaDid1CTMTD4FMsE_1j3t7XyE3AUDYZpkMyP0lsxKEJs5gFI=" rel="nofollow" target="_blank">IBN</a> (<a target="_blank" href="https://www.globenewswire.com/Tracker?data=eji2SInXzxzPDQjO9lBFqhy0I58Dved-K29bI-ktWj7HoKgFBuTiOhZeij5t44GuFCBc5dujzLDKaiF77Y3myLbUVAxfR32sgKWTdiD1MtiOGpjU1VHZL_HVMetFpGUz" rel="nofollow" target="_blank">InvestorBrandNetwork</a>), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the http://www.streetinsider.com/Globe+Newswire/MindBio+Therapeutics+Corp.+%28CSE%3A+MBIO%29+%28OTCQB%3A+MBQIF%29+Harnesses+Key+AI%2C+Voice+Analysis+to+Offer+Impairment+Solution/26490574.html Thu, 14 May 2026 08:30:00 -0400 MBIO MBQIF O.60784024 http://www.streetinsider.com/Press+Releases/Real-Time+Intoxication+Detection+Platforms+Target+Expanding+Multibillion-Dollar+Healthcare+Opportunities/26482356.html <p>AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=2gsxlXne-LqZXT6sSDFos1HYhx4v2ekVcOgZaCxMxYSCHsxLynzYwanyPoGVUNOAd2ka7cGqd0lEXvcz7pjr7sMSvf_4xRcTh3FjnQKJ-P4CWiyYDUYmFMst9028agT7" rel="nofollow" target="_blank">BioMedWire Editorial Coverage</a>: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods http://www.streetinsider.com/Press+Releases/Real-Time+Intoxication+Detection+Platforms+Target+Expanding+Multibillion-Dollar+Healthcare+Opportunities/26482356.html Wed, 13 May 2026 08:30:00 -0400 402340 A.14054101 A.17568957 A.30720309 CAI MBIO MBQIF MDAI NNOX NVDA O.00173616 O.04889877 O.10953170 O.20272049 O.21580210 O.39479336 O.49866460 O.53159796 O.60784024 http://www.streetinsider.com/Press+Releases/Real-Time+Intoxication+Detection+Platforms+Target+Expanding+Multibillion-Dollar+Healthcare+Opportunities/26482356.html <p>AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=2gsxlXne-LqZXT6sSDFos1HYhx4v2ekVcOgZaCxMxYSCHsxLynzYwanyPoGVUNOAd2ka7cGqd0lEXvcz7pjr7sMSvf_4xRcTh3FjnQKJ-P4CWiyYDUYmFMst9028agT7" rel="nofollow" target="_blank">BioMedWire Editorial Coverage</a>: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods http://www.streetinsider.com/Press+Releases/Real-Time+Intoxication+Detection+Platforms+Target+Expanding+Multibillion-Dollar+Healthcare+Opportunities/26482356.html Wed, 13 May 2026 08:30:00 -0400 402340 A.14054101 A.17568957 A.30720309 CAI MBIO MBQIF MDAI NNOX NVDA O.00173616 O.04889877 O.10953170 O.20272049 O.21580210 O.39479336 O.49866460 O.53159796 O.60784024 http://www.streetinsider.com/Press+Releases/Real-Time+Intoxication+Detection+Platforms+Target+Expanding+Multibillion-Dollar+Healthcare+Opportunities/26482356.html <p>AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=2gsxlXne-LqZXT6sSDFos1HYhx4v2ekVcOgZaCxMxYSCHsxLynzYwanyPoGVUNOAd2ka7cGqd0lEXvcz7pjr7sMSvf_4xRcTh3FjnQKJ-P4CWiyYDUYmFMst9028agT7" rel="nofollow" target="_blank">BioMedWire Editorial Coverage</a>: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods http://www.streetinsider.com/Press+Releases/Real-Time+Intoxication+Detection+Platforms+Target+Expanding+Multibillion-Dollar+Healthcare+Opportunities/26482356.html Wed, 13 May 2026 08:30:00 -0400 402340 A.14054101 A.17568957 A.30720309 CAI MBIO MBQIF MDAI NNOX NVDA O.00173616 O.04889877 O.10953170 O.20272049 O.21580210 O.39479336 O.49866460 O.53159796 O.60784024